Related Experiment Video
Updated: Jan 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Incidence and Outcomes of Pericardial Effusion After Congenital Heart Surgery
Mario O'Connor1, Carlos M Mery2, Neil M Venardos3
1Texas Center for Pediatric and Congenital Heart Disease, The University of Texas at Austin Dell Medical School, Austin, TX, USA.
Insights
Pericardial effusion (PCE) after congenital heart surgery (CHS) occurs in 4% of patients, with higher rates after the Norwood procedure. PCE increases length of stay, mortality, and readmissions, necessitating vigilant monitoring.
Area of Science:
- Cardiology
- Pediatric Surgery
- Healthcare Informatics
Background:
- Pericardial effusion (PCE) is a significant postoperative complication following congenital heart surgery (CHS).
- PCE contributes to complex postoperative care, increased morbidity, and resource utilization.
- Identifying risk factors for PCE post-CHS is crucial for improving patient outcomes.
Purpose of the Study:
- To elucidate the risk factors associated with PCE development after CHS.
- To analyze the impact of PCE on postoperative outcomes, including length of stay, mortality, and readmissions.
- To identify specific CHS procedures with higher incidences of PCE.
Main Methods:
- Retrospective analysis of the Pediatric Health Information System Database (2004-2023).
- Inclusion of patients under 18 who underwent Society of Thoracic Surgeons benchmark procedures.
- Multivariable analysis to determine adjusted odds of PCE and its associated outcomes.
Main Results:
- A total of 66,695 surgeries were analyzed, with PCE occurring in 4% of patients.
- The Norwood procedure showed the highest incidence of PCE (8.9%) and adjusted odds (OR: 2.34).
- PCE was associated with increased length of stay (16%), mortality (OR: 1.84), and 90-day readmissions (1%). Fontan patients had the highest readmission rate (1.7%).
Conclusions:
- While the overall incidence of PCE post-CHS is low (4%), specific procedures like the Norwood procedure carry a significantly higher risk (8.9%).
- PCE presents substantial postoperative challenges, leading to increased mortality and resource utilization.
- Targeted monitoring and interventions for high-risk patients are essential to mitigate the adverse effects of PCE.
Abstract:
Introduction: Pericardial effusion (PCE) represents a significant postoperative complication following congenital heart surgery (CHS), contributing to more complex postoperative care and heightened morbidity. In this study, we aim to elucidate the risk factors contributing to PCE development post-CHS through analysis of data from a nationwide, multi-institutional database. Methods: Review of the Pediatric Health Information System Database from January 1, 2004, to December 30, 2023. All patients under the age of 18, who underwent a Society of Thoracic Surgeons benchmark procedure, were included. Results: A total of 66,695 surgeries were identified with 29,363 (44%) female, 35,084 (53%) non-Hispanic white, and median age at surgical admission of 5.1 [interquartile range: 2.0-14.1] months. Pericardial effusion occurred in 2,672 (4%) patients during the postoperative hospitalization, with the Norwood procedure having the highest incidence (245/2,726, 8.9%). Multivariable analysis revealed the Norwood procedure as having the highest adjusted odds of PCE (odds ratio [OR]: 2.34, 95%CI: 1.98-2.75, P < .001) when compared with isolated ventricular septal defect repair. Pericardial effusion was associated with a 16% (95%CI: 9.8-12.3, P < .001) increase in length of stay and increased mortality (OR: 1.84, 95%CI: 1.50-2.25, P < .001). Furthermore, 647 (1%) patients, out of 65,442 who survived to index hospital discharge, were readmitted due to PCE within 90 days of discharge. Fontan patients had the highest incidence of readmission (138/7,873, 1.7%) and increased adjusted odds for readmission (OR: 1.77, 95%CI: 1.37-2.28, P < .001). Conclusions: Incidence of PCE after CHS is low at 4%. However, certain procedures have an incidence as high as 8.9%. Pericardial effusion poses significant postoperative clinical challenges with increased mortality and resource utilization. Vigilant monitoring and targeted interventions in high-risk patients are essential for mitigating the impact of PCE on postoperative outcomes.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiac Catheterization II: Right Heart Catheterization
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pericarditis IV: Nursing Management

